Formation and Characterisation of Posaconazole Hydrate Form
Posaconazole is an API added as Form I for the production of oral suspensions, but it is found as Form-S in the final formulation. In this study, it was found that this polymorphic conversion, which may affect the bioavailability, is due to an interaction with water. However, the relatively poor wet...
Main Authors: | Michail Lykouras, Malvina Orkoula, Christos Kontoyannis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/1/65 |
Similar Items
-
Sample Preparation of Posaconazole Oral Suspensions for Identification of the Crystal Form of the Active Pharmaceutical Ingredient
by: Michail Lykouras, et al.
Published: (2020-12-01) -
Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review
by: Ruochen Qu, et al.
Published: (2024-12-01) -
The effectiveness and safety of posaconazole enteric-coated tablet versus oral suspension in invasive fungal infections
by: Yi-Lei Yang, et al.
Published: (2024-11-01) -
Semiquantitative X-ray Powder Diffraction Analysis in Counterfeit Medicines Investigation—The Viagra Example
by: Armand Budzianowski, et al.
Published: (2023-10-01) -
Structural Identification of Binary Tetrahydrofuran + O2 and 3-Hydroxytetrahydrofuran + O2 Clathrate Hydrates by Rietveld Analysis with Direct Space Method
by: Yun-Ho Ahn, et al.
Published: (2018-08-01)